A study of DKN-01 in patients with endometrioid gynecological cancers
Phase of Trial: Phase II
Latest Information Update: 13 Nov 2017
At a glance
- Drugs DKN 01 (Primary)
- Indications Endometrial cancer; Gynaecological cancer
- Focus Therapeutic Use
- 13 Nov 2017 According to a Leap Therapeutics media release, the company has filed an IND application with the FDA to initiate this trial.
- 17 Aug 2017 New trial record
- 11 Aug 2017 According to a Leap Therapeutics media release, the company anticipates initiating this trial in 2H 2017.